The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab (MSB0010718C; anti-PD-L1) in patients with recurrent/refractory ovarian cancer from the JAVELIN Solid Tumor phase Ib trial: Safety and clinical activity.
 
Mary L. Disis
Stock and Other Ownership Interests - Epithany; VentiRx
Consulting or Advisory Role - Celgene; EMD Serono; Emergent BioSolutions; VentiRx
Research Funding - EMD Serono; Seagen; VentiRx
Patents, Royalties, Other Intellectual Property - I am an inventor on patents held by the University of Washington
 
Manish R. Patel
No Relationships to Disclose
 
Shubham Pant
Consulting or Advisory Role - Celgene; Halozyme
 
Erika Paige Hamilton
No Relationships to Disclose
 
Albert C. Lockhart
Research Funding - Amgen (Inst); Bayer (Inst); CTI (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Teva (Inst); Vertex (Inst); Zenyaku Kogyo (Inst)
 
Karen Kelly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Synta
Research Funding - Abbvie (Inst); Celgene (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Lilly; Roche; Synta
 
J. Thaddeus Beck
Consulting or Advisory Role - Novartis
Research Funding - AbbVie (Inst); Amgen (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); Heat Biologics (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst)
 
Michael S. Gordon
Stock and Other Ownership Interests - Caremission; Medelis
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Lilly/ImClone (Inst); MedImmune (Inst); Merck Serono (Inst); Millennium (Inst); OncoMed (Inst); Pfizer (Inst); Sirtex Medical (Inst)
 
Glen J. Weiss
Employment - Cancer Treament Centers of America
Consulting or Advisory Role - Blend Therapeutics; Paradigm; Pharmatech
Speakers' Bureau - Amgen; Celgene; Medscape; Pfizer; Quintiles
Patents, Royalties, Other Intellectual Property - US Patent #8,911,940 issued 2014 (Inst)
Travel, Accommodations, Expenses - Cambridge Healthtech Institute; Pharmatech
 
Matthew H. Taylor
Consulting or Advisory Role - Eisai; Onyx; PDX Pharmacy
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Eisai (Inst); Merck KGaA (Inst); Novartis (Inst)
 
Jorge Chaves
Employment - Northwest Medical Specialties
Leadership - Northwest Medical Specialties
Stock and Other Ownership Interests - GlaxoSmithKline; Johnson & Johnson
Research Funding - Acerta Pharma; EMD Serono (Inst); Gilead Sciences (Inst); Oncothyreon (Inst)
Travel, Accommodations, Expenses - Halozyme
 
Alain C. Mita
Speakers' Bureau - Genentech
 
Kevin M. Chin
Employment - EMD Serono
Stock and Other Ownership Interests - Bristol-Myers Squibb
Research Funding - EMD Serono (Inst)
 
Anja von Heydebreck
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
 
Jean-Marie Cuillerot
Employment - EMD Serono
 
James L. Gulley
Consulting or Advisory Role - Prime Oncology; TRM Oncology
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology